<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Growths may appear Marijuana is of equal importance, with all the application department upgraded for their products. But not so, because some companies have new approaches shelves for a cultivated and stubborn cannabis that investors expect to have better outcomes and lower costs. CannTrust Contracts (NASDAQOTH: CNTTF), and soon the US investors will get the opportunity buy shares of Canadian agriculture New York Stock Exchange. "data-reactid =" 12 "> Marijuana growers may be of equal importance, by sharing the upgrade demand for their product. But this is not the case, as some companies have taken innovative approaches to cultivating and generating cannabis that expects, expectations, better productivity and lower costs. That is the main claim CannTrust Contracts (NASDAQOTH: CNTTF), and sooner, US investors will be able to buy shares of Canadian agriculture on New York Stock Exchange.
Well Image: CannTrust.
What makes CannTrust a & # 39; stand out?
Against it, CannTrust Holdings looks like just about any other marijuana company. The Canadian cannabis producer, who was chief of the Vaughan borough in Toronto, became an expert in the delivery of medical marijuana products for patients. There are two main tools that come to & # 39; company, one in Vaughan and the other in the Niagara area over the border from Buffalo. To abolish recent recreational cannabis products, CannTrust has expanded its scope to also use an adult market service.
CannTrust is long from the same company to start with a medical cannabis, but there are different ways in which it makes a difference from its competitors. Initially, although its company has been working for less than five years ago, He was a drug maker in founders, Experience more than 40 years in the wider barriers and healthcare to their board. This gave CannTrust a scientific focus, and its company is still committed to research and development with innovative products and production methods that aim to make patients more favorable results of medical marijuana. With a cure partner, CannTrust's production development teams are involved in evidence-based research that has made progress in the industry.
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "CannTrust drive for renovation is paid by workforce that most cannabis companies have been using. CannTrust's production facilities use new hydroponic technology to ensure a steady stream of high quality cannabis products that are free of charge from poisoning. 50,000- A square facility that includes cannabis capacities, as well as coping sections such as cannabis oils and distribution of materials to customers. a larger 430,000-square facility through Niagara using advanced technology that is growing everlasting, with a view to encouraging more output. "data-reactid =" 28 "> CannTrust is driving a costing innovation with an agricultural method that most cannabis companies do not use. CannTrust's production facilities are a new- to ensure that a steady stream of high quality cannabis products is completely free from pesticides. A basic 50,000-square base facility comprises agricultural cannabis capabilities as well as to convene sections such as cannabis-oil that are converted and distributed to customers. The Niagara 430,000-square facility is more and more technology-consuming an increasingly advanced, with a view to bringing forward more output.
How CannTrust is done
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "So far, CannTrust's efforts are a look like them to pay off. In the third quarter financial report, Canadian farmers paid a 12.6 million Canadian dollar income, more than doubled from yearly figures Previously, the number of active protections CannTrust is working to jump over the 50,000 marks. A profitable profit of CA $ 421,000, although there are huge changes for these figures Changes in fair value on biological assets"data-reactid =" 30 "> Until now, CannTrust's efforts seem to be paid off. In the third quarter financial report, Canadian farming Revenue of 12.6 million Canadian dollars, more than doubled from previous year figures, and the number of active patients who CannTrust can attend over 50,000 marks. CannTrust referred to a small profit of CA $ 421,000, although these major changes include major changes for changes in the right value of any property -electric.
CannTrust has higher expectations. The company made the first ferry of oil; has been going to Cannabis to Denmark, where he is the only provider. at present. Collaboration with researchers in Canada and Australia aims to make more use for medical cannabis, and after the end of CannTrust became a strategic partnership with an Australian representative for building a 1.7-square-glass greenhouse. In addition, buying land near Niagara's Greenhouse will allow CannTrust to further develop further in the future.
Coming soon to NYSE
It is because of these successes that CannTrust is now feeling comfortable with & # 39; making efforts to record their common shares on New York Stock Exchange. Chief Executive Peter Aceto said: "CannTrust is firmly established as one of the leading licensing makers in Canada, with a global platform in science and innovation. The US is a natural step forward in our development as we are expanding our focus on expanding and expanding our business on an international scale. "
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "CannTrust is not the first stock of marijuana what to do is move to NYSE, and it not the last oneNext Post, with his innovative approach to cannabis business, CannTrust deserves close attention from US investors as he is preparing to record its shares on Wall Street. "Data-reactid =" 38 "> CannTrust is not the first stock of marijuana to make the move in NYSE, and not the last thing. But with an innovative approach to cannabis business, CannTrust is worthy of close attention from US investors as it is preparing to record its shares on Wall Street.
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = " More from The Motley Fool "data-reactid =" 39 "> More from The Motley Fool
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Dan Caplinger there is no place in any of the stocks mentioned. The Motley Fool praises CannTrust Holdings Inc. There is Motley Fool who has publishing policySouth Westerly"data-reactid =" 44 ">Dan Caplinger is not in any situation named. Motley Fool praises CannTrust Holdings Inc. Motley Fool's publishing policy.